Celldex Therapeutics shares owned by SG Americas Securities
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by SG Americas Securities
from 13F filings
Historical chart of SG Americas Securities investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by SG Americas Securities consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by SG Americas Securities
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $504k | 20k | 25.89 |
| 2025-03-31 | $633k | 35k | 18.15 |
| 2024-12-31 | $639k | 25k | 25.27 |
| 2024-09-30 | $691k | 20k | 34.01 |
| 2024-06-30 | $335k | 9.0k | 37.04 |
| 2024-03-31 | $851k | 20k | 41.97 |
| 2023-12-31 | $1.8M | 46k | 39.67 |
| 2023-09-30 | $2.1M | 78k | 27.52 |
| 2023-06-30 | $167k | 4.9k | 33.86 |
| 2023-03-31 | $374k | 10k | 36.00 |
| 2022-12-31 | $303k | 6.8k | 44.55 |
| 2022-09-30 | $367k | 13k | 28.08 |
| 2022-06-30 | $1.5M | 56k | 26.96 |
| 2022-03-31 | $475k | 14k | 34.03 |
| 2021-12-31 | $390k | 10k | 38.66 |
| 2021-09-30 | $1.1M | 20k | 54.00 |
| 2020-12-31 | $440k | 25k | 17.53 |